Browse > Article

Expression and Purification of Recombinant Human Interferon-gamma Produced by Escherichia coli  

Park, Jung-Ryeol (AceBiotech Co., Ltd.)
Kim, Sung-Woo (AceBiotech Co., Ltd.)
Kim, Jae-Bum (AceBiotech Co., Ltd.)
Jung, Woo-Hyuk (AceBiotech Co., Ltd.)
Han, Myung-Wan (Department of Chemical Engineering, Chungnam National University)
Jo, Young-Bae (AceBiotech Co., Ltd.)
Jung, Joon-Ki (Korea Research Institute of Bioscience and Biotechnology)
Publication Information
KSBB Journal / v.21, no.3, 2006 , pp. 204-211 More about this Journal
Abstract
For the production of the recombinant human interferon-gamma(rhIFN-${\gamma}$) in Escherichia coli, human glucagon and ferritin heavy chain were used as fusion partners. Even though rhIFN-${\gamma}$ is expressed as an inclusion body form in E. coli because of strong hydrophobicity of itself, over 50% of fused rhIFN-${\gamma}$ was expressed as soluble form in E. coli $Origami^{TM}$(DE3) harboring pT7FH(HE)-IFN-${\gamma}$ which encodes ferritin heavy chain-fused rhIFN-${\gamma}$. In the case of using glucagon-ferritin heavy chain hybrid mutant as a fusion partner, 6X His-tag was additionally introduced to N-terminus of GFHM(HE)-IFN-${\gamma}$ for enhancing purification yields of rhIFN-${\gamma}$. Fusion protein HGFHM(HE)-IFN-${\gamma}$ with two 6X His-tag was more effectively bound to Ni-NTA agarose bead than GFHM(HE)-IFN-${\gamma}$ with a 6X His-tag. rhIFN-${\gamma}$ was completely purified from enterokinase-treated HGFHM(HE)-IFN-${\gamma}$ by Ni-NTA affinity column. For high-level production of rhIFN-${\gamma}$, glucose was used as the sole carbon source with simple exponential feeding rate($2.4{\sim}7.2g/h$) in fed-batch process. The effective lactose concentration for the expression of the rhIFN-${\gamma}$ was $10{\sim}20mM$. Under the fed-batch culture conditions, rhIFN-${\gamma}$ production yield reached 11 g DCW/L for 6 hours after lactose induction.
Keywords
Recombinant human interferon-gamma; expression; purification; glucagon; ferritin heavy chain;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Naylor, S. L., A. Y. Sakaguchi, T. B. Shows, M. L. Law, D. V. Goeddel, and P. W. Gray (1983), Human immune interferon gene is located on chromosome 12, J. Exp. Med. 57, 1020-1027
2 Goldberg, M. M., L. S. Belkowski, and B. R. Bloom (1989), Regulation of macrophage growth and antiviral activity by interferon-gamma, J. Cell Biol. 109, 1331-1340   DOI
3 Shin, C. S., M. S. Hong, C. S. Bae, D. Y. Kim, H. C. Shin, and J. Lee (1988), Growth-associated synthesis of recombinant human glucagon and human growth hormone in high-cell-density cultures of Escherichia coli, Appl. Microbiol. Biotechnol. 49, 364-370   DOI
4 Saraswat, V., J. Lee, D. Y. Kim, and Y. H. Park (2000), Synthesis of recombinant human interleukin-2 via controlled feed of lactose - complex media in fed-batch cultures of Escherichia coli BL21(DE3) [pT7G3-IL2] Biotechnol. Letters 22, 261-265   DOI   ScienceOn
5 Sambrook, J. and D. W. Russell (2001), Molecular Cloning - a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press
6 Bradford, M. M. (1976), A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248-254   DOI   ScienceOn
7 Gattacceca, F., Y. Pilatte, C. Billard, I. Monnet, S. Moritz, J. Le Carrou, M. Eloit, and M.-C. Jaurand (2002), Ad-IFN-$\gamma$ induces antiproliferative and antitumoral responses in malignant mesothelioma, Clin. Cancer Res. 8(10), 3298-3304
8 Loosdrecht, van de A., G. J. Ossenkoppele, R. H. Beelen, M. G. Broekhoven, M. M. Langenhuijsen (1992), Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line, Cancer Immunol. Immunother. 34(6), 393-398   DOI
9 Shuai, K., J. Liao, and M. M. Song (1996), Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1, Mol. Cell Biol. 16(9), 4932–4941
10 Pfeffer, L. M., C. A. Dinarello, R. B. Herberman, B. R. Williams, E. C. Borden, R. Bordens, M. R. Walter, T. L. Nagabhushan, P. P. Trotta, and S. Pestka (1998), Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons, Cancer Res. 58(12), 2489-2499
11 Isaacs, A., J. Lindemann, and R. C. Valentine (1957), Virus interference. II. Some properties of interferon, Proc. Roy. Soc. London (Biol). 147(B), 268-273
12 Smith, M. R., K. Muegge, J. R. Keller, H.-F. Kung, H. A. Young, and S. K. Durum (1990), Direct evidence for an intracellular role for IFN-$\gamma$: microinjection of human IFN-$\gamma$ induces Ia expression on murine macrophages, J. Immunol. 144, 1777-1782
13 Pestka, S. (1997), The human interferon-alpha species and hybrid proteins, Semin. Oncol. 24(suppl. 9), S9-4-S9-17
14 Alonso, A., G. Morales, R. Escalante, E, Campanario, L, Sastre, and J. L. Martinez (2004), Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology, J. Antimicrob. Chemother. 53, 432-434   DOI   ScienceOn
15 Nagata, S., H. Taira, A. Hall, L. Johnstrud, M. Streuli, J. Escodi, W. Boll, K. Cantell, and C. Weissmann (1980), Synthesis in E. coli of a polypeptide with human leukocyte interferon activity, Nature 284, 316-320   DOI   ScienceOn
16 Mehta, K., R. L. Juliano, and G. Lopez-Berestein (1984), Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites, Immunology 51, 517-527
17 Sreevalsan, T. (1995), Biological therapy with Interferon-alfa and beta: preclinical studies. In: DeVita V. T. J., S. M. D. Hellman, S. A. Rosenberg, eds. Biologic Therapy of Cancer, 2nd ed., Philadelphia: J. B. Lippincott Company, 347-364
18 Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, T. A. Stewart (1993), Multiple defects of immune cell function in mice with disrupted interferon-gamma genes, Science 259(5102), 1739-1742   DOI   ScienceOn
19 Billiau, A. A., H. Heremans, K. Vermeire, and P. Matthys (1998), Immunomodulatory Properties of Interferon-$\gamma$: An Update, Ann. N.Y. Acad. Sci., 856(1), 22-32   DOI
20 Nagata, S., N. Mantei, and C. Weissmann (1980), The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha, Nature 287, 401-408   DOI   ScienceOn
21 Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (2002), Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology, 5th ed. John Wiley & Sons, Inc
22 Buchel, D. E., B. Gronenborn, and B. Muller-Hill (1980), Sequence of the lactose permease gene, Nature 283, 541-545   DOI   ScienceOn
23 Sasaki, K., S. Dockerill, D. A. Adamiak, I. J. Tickle, and T. Blundell (1975), X-ray analysis of glucagon and its relationship to receptor binding, Nature 257, 751-757   DOI   ScienceOn
24 Fidler, I. J., W. E. Fogler, E. S. Kleinerman, and I. Saiki (1985), Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-$\gamma$ encapsulated in liposomes, J. Immunol. 135, 4289-4296
25 Lee, J., S. W. Kim, Y. H. Kim, and J. Y. Ahn (2002), Active human ferritin H/L-hybrid and sequence effect on folding efficiency in Escherichia coli, Biochem. Biophys. Res. Commun. 298, 225-229   DOI   ScienceOn
26 Kaback, H. R., S. Frillingos, H. Jung, K. Jung, G. G. Prive, M. L. Ujwal, C. Weitzman, J. Wu, and K. Zen (1994), The lactose permease meets Frankenstein, J. Exp. Biol. 196, 183-195